# Translational Core for Therapeutic and Diagnostic Development

> **NIH NIH P30** · UNIVERSITY OF ILLINOIS AT CHICAGO · 2020 · $104,845

## Abstract

PROJECT SUMMARY: TRANSLATIONAL CORE FOR THERAPEUTIC AND DIAGNOSTIC 
DEVELOPMENT 
The newly proposed Translational Core for Therapeutic and Diagnostic Development will fulfill the needs of a 
growing number of investigators engaged in translational research to advance new therapeutic and diagnostic 
tools for ophthalmic diseases. This Core provides resources for scientists and clinicians to bring clinical 
observations to the laboratory, investigate these findings in the laboratory and take new understanding back to 
the clinic or vice versa. The goals will be to provide facilities, expertise, and services for: 1) clinical 
biosampling and phenotyping (Clinic to Lab), 2) first-in-human and mechanistic studies (Lab to Clinic), 3) 
consultation and assistance in biostatistical and analyses of research data, and 4) cutting-edge and secured 
computing facilities, advanced software, expertise and assistance in research protocol development. The 
proposed goals are meant to provide dedicated support services to accelerate therapeutic and diagnostic 
development.

## Key facts

- **NIH application ID:** 10020555
- **Project number:** 2P30EY001792-41
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT CHICAGO
- **Principal Investigator:** Mark I Rosenblatt
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $104,845
- **Award type:** 2
- **Project period:** 1997-09-01 → 2021-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10020555

## Citation

> US National Institutes of Health, RePORTER application 10020555, Translational Core for Therapeutic and Diagnostic Development (2P30EY001792-41). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10020555. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*